Stroke can come out of the blue, even in people who have been healthy all their lives. Unlike some other health conditions that develop gradually, a stroke occurs suddenly when blood flow to the brain ...

Coinciding with the FDA’s clearance for the catheter, Perfuze has also completed a €22m ($24m) financing round.

HealthDay News — Self-perceived stress is associated with cryptogenic ischemic stroke (CIS), according to a study published online March 5 in Neurology.

MicroTransponder has received $65m in a Series F financing round, which aims to enhance its stroke care offerings with the ...

A clot-busting drug recently approved to treat acute ischemic strokes (AIS) that can be delivered quickly works as well as a ...

Researchers at the Technical University of Munich (TUM) have developed a system that helps patients learn to move their ...

The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.

Ischemic stroke is a fatal condition caused by an arterial embolism that blocks the blood flow through the cerebral artery, frequently being a cause of mortality and disability. Fibroblast growth ...

A new study has found a strong link between stress and the risk of early-onset cryptogenic ischemic stroke (CIS). This is a stroke where a blood clot blocks blood flow to the brain, it occurs in young ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Tris Pharma announced positive topline results from the ALLEVIATE-2 phase III clinical trial of investigational cebranopadol to treat moderate-to-severe acute pain after bunionectomy surgery. Axonal ...

(HealthDay News) — The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.